KALAMAZOO, Mich. — A new antibody shot could help infants who contract respiratory syncytial virus, or RSV. Beyfortus is a ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Local mother Lindsay Carter’s son, S.J., got severely sick with RSV two years ago. He was just 10 months old. “It wa ...

To protect infants from RSV, vaccination is recommended during pregnancy, and monoclonal antibody treatment is advised for ...

Shanghai Ark Biopharmaceutical (ArkBio) has concluded enrolment and dosing for a Phase I trial of fully human monoclonal ...

Among adults with outpatient respiratory syncytial virus (RSV) infections across six RSV seasons, roughly one in 20 were ...

Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Enanta Pharmaceuticals (ENTA – Research Report). The associated ...

Approximately 1 in 20 adults with outpatient respiratory syncytial virus (RSV) infections were readmitted to the hospital ...

Respiratory syncytial virus (RSV) and walking pneumonia, while sharing some common symptoms like cough and fever, have ...

The "Respiratory Syncytial Virus (RSV) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. "Respiratory Syncytial Virus (RSV)- Pipeline Insight, 2024" report ...

NEW ALBANY, Miss. (WTVA) — Respiratory syncytial virus (RSV) is a big threat this time of year. RSV is a contagious virus ...

targeting respiratory syncytial virus (RSV) and malaria utilizing the company’s proprietary C1 protein production platform to provide globally accessible treatment options for underserved populations.